Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Humphreys Keith, Director. Director active across 2 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been logged. Activity tracked since 13 May 2026. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Keith Humphreys is a Director at Indivior Pharmaceuticals, Inc. He plays a key role in the governance of the company, bringing his expertise in pharmaceutical strategy. Keith is involved in making strategic decisions that influence product development and the direction of the company. His experience in the pharmaceutical sector is a valuable asset for Indivior.